e.krastev
TL2 Moderator · Ilorin
Contributes reviews on supplier material. Based in Ilorin.
Joined 17 June 2025 · last posted 9d · groups: regional-apac
80Posts here
1Topics
1Solutions
603Likes received
603Likes given
22Badges
174Days visited
3.1kPosts read
Recent activity
Full stream-
Revisiting: Protein density versus volume when you cannot eat much Replied, post #81 · Nutrition & Training › Protein & intake · 19 Jul 2026 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
About the Adverse events category Replied, post #6 · Safety › Adverse events · 15 Jul 2026 · 0 likes How to document: date, exact symptom or event, severity, duration, outcome, any medical attention sought. Detailed documentation is far more useful than a vague report.
-
Revisiting: Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Replied, post #84 · Evidence › Journal club · 6 Jul 2026 · 30 likes TRIUMPH (ongoing): Retatrutide phase 3. No results yet. Nothing should be attributed to it because it has not finished. When it does, this discussion will return to it.
-
Why the timeline is on the right and not the left — what changed since Replied, post #67 · Meta › Site feedback · 4 Jul 2026 · 10 likes Bugs and friction: the parts of the site that do not work the way you expected. Report them specifically (what you did, what you expected, what happened instead) so…
-
Historical amylin analogues and what happened to them Replied, post #24 · Compounds › Cagrilintide & amylin analogues · 27 Jun 2026 · 7 likes Worth separating two things that post #20 runs together. The CagriSema phase 2 paper: a fixed combination of the two components in one weekly injection. The trade-off…
-
Second pass at: Programming during a large energy deficit Replied, post #46 · Nutrition & Training › Resistance training · 26 Jun 2026 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Named, unnamed and unspecified impurities as regulatory categories — the long version Replied, post #19 · Analytics › Impurities & related substances · 23 Jun 2026 · 14 likes Residual solvents: traces of solvents used in purification. These are usually tested by gas chromatography, not by HPLC. A specification for residual solvents should be…
-
Trust level 3 requirements: a clarification — does this still hold? Replied, post #69 · Meta › Announcements · 22 Jun 2026 · 0 likes post #68 is right about the mechanism and I think understates the practical bit. Thank you for the correction. I have edited my earlier post with a note rather than…
-
GLP-1 receptor distribution: central and peripheral Replied, post #73 · Pharmacology › Receptor biology · 20 Jun 2026 · 6 likes Central versus peripheral action: GLP-1 agonism works through both central nervous system effects (appetite) and peripheral effects (gastric motility, insulin). The…
-
What to include when your question involves a chromatogram — one year on Replied, post #39 · Start Here › How to Ask · 16 Jun 2026 · 2 likes Chromatogram questions: describe the method first. Column type, gradient, wavelength, detection method. Everything else follows from method. A chromatogram without…
-
Coming back to: Reconciling a supplier certificate with an independent result Replied, post #14 · Sourcing › Vendor reports · 14 Jun 2026 · 20 likes post #13 answers the question as asked. The question underneath it is different. For anyone arriving from a search: the marked solution above is the direct answer, and…
-
Submitting a sample: the process end to end Replied, post #15 · Sourcing › Independent verification · 13 Jun 2026 · 19 likes PeptideMeter: purity analysis plus structured, dated supplier verification records. Produces both individual analytical results and verification records assessed over…